Enlyte Launches NJ DPR+ to Support Auto Injury Claim Management in New Jersey
SAN DIEGO, Feb. 29, 2024 /PRNewswire/ -- Satisfying the requirements of the New Jersey Automobile Insurance Cost Reduction Act has been a significant challenge for insurers who provide auto coverage in the Garden State. This includes filing a decision point review (DPR) plan that ensures the injured party has access to providers and services for medically necessary treatment, diagnostic testing, and durable medical equipment at various stages of recovery.
- To help meet these requirements, Enlyte, the parent brand of Mitchell, Genex and Coventry, has launched NJ DPR+, a fully integrated, comprehensive solution providing auto insurers national support for bill review workflows in New Jersey.
- NJ DPR+ integrates Genex's clinical expertise, Coventry's network provider reach, and Mitchell's technology and bill review proficiency to seamlessly manage the claim.
- The solution lets insurers craft their DPR filing in New Jersey or have Enlyte assist them with the filing process.
- The DPR+ approach leverages utilization management, case management review, independent medical exams and/or medical director review outcomes for New Jersey claims.